Therapeutic Targeting of Oxidative Phosphorylation in Microsatellite Instability-High Gastric Cancer
Authors:
Open Access
- 30 March 2026
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 17 (4) , 797-807
Abstract
Background: Gastric cancer is the third leading cause of cancer-related mortality worldwide. According to The Cancer Genome Atlas (TCGA), it can be classified into four molecular subtypes, including microsatellite instability (MSI) and genomically stable (GS) subtypes, which display distinct clinical and pathological features. However, differences in their tumor microenvironment, particularly metabolic reprogramming, remain poorly understood.Keywords
This publication has 38 references indexed in Scilit:
- Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationshipCancer Letters, 2018
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesNature Medicine, 2015
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Causes and consequences of microsatellite instability in gastric carcinogenesisWorld Journal of Gastroenterology, 2014
- Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activationHuman Molecular Genetics, 2011
- Clinicopathologic characteristics and outcomes of gastric cancers with the MSI‐H phenotypeJournal of Surgical Oncology, 2008
- Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancersSurgery, 2006
- Distinct Clinical Features and Outcomes of Gastric Cancers with Microsatellite InstabilityLaboratory Investigation, 2002
- A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.1998
- A genetic model for colorectal tumorigenesisCell, 1990